103 related articles for article (PubMed ID: 21809991)
1. Immunohistochemical study of correlation between histologic subtype and expression of epithelial-mesenchymal transition-related proteins in synovial sarcomas.
Subramaniam MM; Navarro S; Llombart-Bosch A
Arch Pathol Lab Med; 2011 Aug; 135(8):1001-9. PubMed ID: 21809991
[TBL] [Abstract][Full Text] [Related]
2. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
3. The correlation between morphology and the expression of TGF-β signaling pathway proteins and epithelial-mesenchymal transition-related proteins in synovial sarcomas.
Qi Y; Wang CC; He YL; Zou H; Liu CX; Pang LJ; Hu JM; Jiang JF; Zhang WJ; Li F
Int J Clin Exp Pathol; 2013; 6(12):2787-99. PubMed ID: 24294365
[TBL] [Abstract][Full Text] [Related]
4. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma.
Saito T; Nagai M; Ladanyi M
Cancer Res; 2006 Jul; 66(14):6919-27. PubMed ID: 16849535
[TBL] [Abstract][Full Text] [Related]
5. The SYT-SSX fusion protein and histological epithelial differentiation in synovial sarcoma: relationship with extracellular matrix remodeling.
Saito T
Int J Clin Exp Pathol; 2013; 6(11):2272-9. PubMed ID: 24228088
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin mutation and Snail overexpression as alternative mechanisms of E-cadherin inactivation in synovial sarcoma.
Saito T; Oda Y; Kawaguchi K; Sugimachi K; Yamamoto H; Tateishi N; Tanaka K; Matsuda S; Iwamoto Y; Ladanyi M; Tsuneyoshi M
Oncogene; 2004 Nov; 23(53):8629-38. PubMed ID: 15467754
[TBL] [Abstract][Full Text] [Related]
7. Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.
Cao YW; Wan GX; Sun JP; Cui XB; Hu JM; Liang WH; Zheng YQ; Li WQ; Li F
Kaohsiung J Med Sci; 2015 Feb; 31(2):70-6. PubMed ID: 25645984
[TBL] [Abstract][Full Text] [Related]
8. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features.
Saito T; Oda Y; Sugimachi K; Kawaguchi K; Tamiya S; Tanaka K; Matsuda S; Sakamoto A; Iwamoto Y; Tsuneyoshi M
Am J Pathol; 2001 Dec; 159(6):2117-24. PubMed ID: 11733362
[TBL] [Abstract][Full Text] [Related]
10. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
Gasior K; Hauck M; Wilson A; Bhattacharya S
Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
[TBL] [Abstract][Full Text] [Related]
11. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
12. Neoplastic spindle cells in nasopharyngeal carcinoma show features of epithelial-mesenchymal transition.
Luo WR; Chen XY; Li SY; Wu AB; Yao KT
Histopathology; 2012 Jul; 61(1):113-22. PubMed ID: 22486228
[TBL] [Abstract][Full Text] [Related]
13. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-to-mesenchymal transition in metaplastic breast carcinomas with chondroid differentiation: expression of the E-cadherin repressor Snail.
Gwin K; Buell-Gutbrod R; Tretiakova M; Montag A
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):526-31. PubMed ID: 20697265
[TBL] [Abstract][Full Text] [Related]
15. Snail promotes lymph node metastasis and Twist enhances tumor deposit formation through epithelial-mesenchymal transition in colorectal cancer.
Fan XJ; Wan XB; Yang ZL; Fu XH; Huang Y; Chen DK; Song SX; Liu Q; Xiao HY; Wang L; Wang JP
Hum Pathol; 2013 Feb; 44(2):173-80. PubMed ID: 22974478
[TBL] [Abstract][Full Text] [Related]
16. Sarcomatoid renal cell carcinoma is an example of epithelial--mesenchymal transition.
Conant JL; Peng Z; Evans MF; Naud S; Cooper K
J Clin Pathol; 2011 Dec; 64(12):1088-92. PubMed ID: 22003062
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin regulators are differentially expressed in the epithelium and stroma of keratocystic odontogenic tumors.
Porto LP; dos Santos JN; Ramalho LM; Figueiredo AL; Carneiro Júnior B; Gurgel CA; Paiva KB; Xavier FC
J Oral Pathol Med; 2016 Apr; 45(4):302-11. PubMed ID: 26525778
[TBL] [Abstract][Full Text] [Related]
18. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug.
Wu J; Ru NY; Zhang Y; Li Y; Wei D; Ren Z; Huang XF; Chen ZN; Bian H
Oncogene; 2011 Oct; 30(43):4410-27. PubMed ID: 21532623
[TBL] [Abstract][Full Text] [Related]
19. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
20. Laser capture microdissection for detecting the expression of epithelial-mesenchymal transition-related genes in epithelial and spindle cells of paraffin-embedded formalin-fixed biphasic synovial sarcoma.
Wang N; Liu ZH; Zou H; Pang LJ; Gu WY; Hu JM; Li DM; Zhao J; Zhang J; Liu CX; Zhang WJ; Qi Y; Li F
Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):675-682. PubMed ID: 29575169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
